Adoptive cell therapy based on ex-vivo expanded tumor-infiltrating lymphocytes (TILs) has historically been most effective in ...

A novel approach to tumor-infiltrating lymphocyte therapy yielded higher response rates among patients with metastatic ...

Abatacept is a disease-modifying antirheumatic drug (DMARD) used in the management of rheumatic conditions, such as ...

Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited tumor-infiltrating lymphocytes (TILs) may be ...

A WOMAN who was told she had a nasty chest infection after suffering from a persistent cough discovered it was actually a ...

SunAct Advanced Cancer Therapies launches third advanced oncology centre at Dr. Gupte Hospital, Khar, Mumbai: Our Bureau, ...

Low-grade systemic inflammation is an independent risk factor for psoriasis, especially moderate to severe disease, results ...

DelveInsight's "Large Granular Lymphocyte Leukemia Market Insights, Epidemiology, and Market Forecast- 2032" report delivers ...

A new study reveals the C-reactive protein-albumin-lymphocyte (CALLY) index is a strong predictor of long-term survival in ...

Neoadjuvant PD-1 blockade in early-stage mismatch repair–deficient solid rectal and non-rectal tumors can eliminate the need ...